Using paclitaxel as an immunomodulator to enhance T cell-mediated therapeutic efficacy in lymphoma-bearing mice
碩士 === 國立陽明大學 === 生物醫學影像暨放射科學系 === 101 === Adoptive cell therapy (ACT) provides a promising therapeutic strategy for cancer treatment using ex vivo generated tumor-specific cytotoxic T-cells (CD8+ T-cells). Therapeutic efficacy of ACT, however, is often unsatisfied due to cytotoxic T-cells affected...
Main Authors: | Tzu-Chun Chen, 陳姿鈞 |
---|---|
Other Authors: | Jeng-Jong Hwang |
Format: | Others |
Language: | en_US |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/29893425994809417915 |
Similar Items
-
Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine
by: Claire Smalley Rumfield, et al.
Published: (2020-06-01) -
Immunomodulation in Cutaneous T Cell Lymphoma
by: Martina Ferranti, et al.
Published: (2019-10-01) -
Nanomaterials-Mediated Immunomodulation for Cancer Therapeutics
by: Ajita Jindal, et al.
Published: (2021-02-01) -
Regulatory T cells mediated immunomodulation during asthma: a therapeutic standpoint
by: Mohammad Afzal Khan
Published: (2020-12-01) -
Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application
by: Byung-Chul Lee, et al.
Published: (2020-09-01)